Research map: Tutorial on non inferiority trial in pharmaceutical research: an important and applied issue

Back to the article

Papers in this map

  1. Randomised controlled trials – the gold standard for effectiveness research · Eduardo Hariton · 2018 · 1654 citations · Cited by this paper
  2. Discovery of a novel VEGFR2 inhibitor using integrated structure-based docking study and functional validation: potential applications in targeted cancer therapy · 2026 · Related
  3. Challenges in the Design and Interpretation of Noninferiority Trials · Laura Mauri · 2017 · 391 citations · Cited by this paper
  4. Coaxial electrospun fibers for control release of vancomycin and diclofenac in osteomyelitis management · 2025 · Related
  5. Methodology of superiority vs. equivalence trials and non-inferiority trials · Erik Ilsø Christensen · 2007 · 216 citations · Cited by this paper
  6. Inhalable nanoparticle-based drug delivery system for non-small cell lung cancer therapy: promises and challenges · 2025 · Related
  7. Non-inferiority study design: lessons to be learned from cardiovascular trials · Stuart J. Head · 2012 · 170 citations · Cited by this paper
  8. Assessment of the feasibility of including community pharmacies under the regulation of the saudi food and drug authority · 2025 · Related
  9. Non-inferiority clinical trials: Practical issues and current regulatory perspective · Sandeep Kumar Gupta · 2011 · 30 citations · Cited by this paper
  10. Phytochemical profiling and antidiarrheal activity of Sophora japonica L. fruit extract · 2026 · Related
  11. Understanding superiority, noninferiority, and equivalence for clinical trials · Rahul Mahajan · 2020 · 30 citations · Cited by this paper
  12. Current status and trends of anti-tumor biosimilars in China from 2019 to 2023: A cross-sectional analysis · 2025 · Related
  13. Estudos clínicos de não-inferioridade: fundamentos e controvérsias · Valdair F. Pinto · 2010 · 29 citations · Cited by this paper
  14. Botulinum neurotoxin: from molecular pathogenesis to emerging countermeasures · 2026 · Related
  15. Understanding three standard study designs for randomized controlled trials · Naoko Niimi · 2024 · 9 citations · Cited by this paper
  16. Empagliflozin improves renal injury of diabetic nephropathy complicated with hyperuricemia through AMPK by promoting autophagy and inhibiting apoptosis · 2026 · Related
  17. Key insights and challeneges in noninferiority trials · Boohwi Hong · 2024 · 9 citations · Cited by this paper
  18. Therapeutic potential of canagliflozin in DEN/TAA-induced renal cancer: mechanistic insights into NLRP3/IL-6/STAT3 and AMPK signaling and oxidative stress regulation · 2025 · Related
  19. Comparing Articaine brands: A randomized non-inferiority controlled trial · David Arboleda-Toro · 2021 · 2 citations · Cited by this paper
  20. Co-amorphization for solubility and dissolution rate improvement: the case of low-crystallization-tendency drugs · 2026 · Related

Source: OpenAlex (CC0)